• The document is an intimation regarding the availability of the audio recording for the Q1FY2027 Earnings Conference Call.
  • The event type is specifically described as an "Earnings Conference Call" for Q1 FY2027 results.
  • The recording was made available on August 14, 2026, as indicated by the signing date of the disclosure.
  • The stated purpose of the event was to discuss Q1 FY2027 earnings, though no specific financial details or management commentary are provided in this announcement.
  • The company has made the audio recording available on its official investor relations website at https://www.alkemlabs.com/investors/earnings-call.
  • Management participants are not specified in this particular disclosure.
  • The document serves as a compliance filing under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Additional Notes Section

  • This is a pure compliance disclosure announcing the availability of the earnings call recording without containing any financial data, results, or strategic updates.
  • The document was signed by Manish Narang, President – Legal, Company Secretary & Compliance Officer of Alkem Laboratories Limited.
  • The disclosure was formally submitted to both BSE Limited and National Stock Exchange of India Limited.